microdose glp 1 perimenopause PSA for all the women on GLP-1s and hormone replacement therapy (HRT GLP-1 Microdosing 2026: 0.1mg Chart

A full day

Tirzepatide showed the greatest reduction in likelihood of depression for diabetic patients (65%), as shown in Figure 1

In a seminal study by Day et al., 48 several co-agonists with different GLP-1-to-GCG receptor ratios were investigated in murine models and the optimal balance was suggested to be a co-agonist with equal potency on both receptors

Additionally, failing to rotate injection sites can cause lipodystrophy a condition where fatty tissue builds up in certain areas, creating hard lumps or dents that can interfere with medication absorption

Gallbladder symptoms, conversely, tend to be more severe, localized, and may worsen over time rather than improve

For most medications, this delay is clinically insignificant